The startup is now looking for a lead investor for its Series A round to fund the company’s go-to market roadmap.
Image: Sam Owen is founder and CEO of D.C.-based Otolith Labs ALEXANDRA WHITNEY PHOTOGRAPHY
Home » Otolith Labs raising Series A to get medical device for vertigo to Food and Drug Administration – Washington Business Journal
The startup is now looking for a lead investor for its Series A round to fund the company’s go-to market roadmap.
Image: Sam Owen is founder and CEO of D.C.-based Otolith Labs ALEXANDRA WHITNEY PHOTOGRAPHY
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
Twitter
Facebook
Linkedin
© 2024 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.